FIDELTransfidelity
$0.0053
$0.00007627
(1.47%)
Mkt Cap$5,266.02
Vol70.43
<
...
1
>
Bullish/Bearish Forum Sentiment
Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Message Board Activity
Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Discussion Diversity
Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
AboutNeurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates. Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia. Despite the significant research funding allocated to neurodegenerative diseases, current therapies continue to treat the symptoms caused by the protein aggregates, with little progress made to stop or reverse disease. We’re trying to go after a potential root cause - rather than trying to clear aggregates once they are there, we aim to prevent them from forming in the first place by reducing the production of faulty proteins. With a clear path towards developing novel intellectual property (IP) and an ever-growing target market, we believe we are poised to make an impact on neurodegenerative disorders and the way we age.
DetailsCategories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
June 26, 2026
$5,266.02
$70.43
---
June 26, 2026
$5,224.11
$64.09
---
June 25, 2026
$5,180.85
$33.12
$0.0052
June 24, 2026
$5,316.64
$53.06
$0.0053
June 23, 2026
$5,160.68
$41.71
$0.0052
June 22, 2026
$5,297.89
$30.12
$0.0053
June 21, 2026
$5,577.51
$35.50
$0.0056
June 20, 2026
$5,703.28
$63.41
$0.0057
June 19, 2026
$5,954.21
$145.25
$0.006
June 18, 2026
$5,764.68
$171.95
$0.0058